1. Why fund dozens of biolabs worldwide manipulating infectious diseases (including SARS-CoV-2 elements) with minimal oversight?
Dual-use research—civilian biosecurity masking offensive/defensive bioweapons potential—serves multiple interlocking interests. Geopolitically, the U.S. (& peers) maintained advantage in a post-Soviet world by securing/dual-purposing former Soviet labs (e.g., Ukraine programs) & partnering in hotspots like Wuhan via EcoHealth & NIH grants. This creates leverage: pathogen libraries for countermeasures (or escalation dominance), surveillance of rivals’ capabilities, & plausible deniability.
Wealth ties in via contracts: defense/intel budgets flow to contractors, universities & pharma for “preparedness.” Oversight stays thin because transparency risks exposure of gain-of-function (GoF) work that blurs research & weaponization. Psychologically, this reflects elite overconfidence—“we can manage the risks”—coupled with institutional inertia. Revelations of 120 U.S.-linked sites confirm a sprawling network; the “why” is power preservation in an era of great-power competition. Accidents or releases test resilience while rivals bear blame.
2. Why ignore vaccine dangers, lie about safety/efficacy?
Simple. Public health agencies became extensions of pharmaceutical-government complexes. Emergency Use Authorization, liability shields (PREP Act) & Warp Speed billions created massive incentives to prioritize speed & uptake over long-term signals. Once committed, admitting risks (myocarditis, excess mortality correlations in some datasets, waning efficacy) triggers legal, reputational & funding collapse.
Psychologically: groupthink careerism. Dissenters face deplatforming (as w/ lab-leak skeptics early on). Collectively, it signals “trust the science” as a control mechanism during crisis—fear binds populations. Data suppression or reframing (“safe & effective” as mantra) protects the golden goose of mRNA platforms & future pandemic contracts. Not every actor knew every harm, but institutional self-preservation favored narrative over nuance.
3. Why push masks & lockdowns despite limited efficacy & natural immunity costs?
These were visible theater for perceived action & compliance enforcement. Masks offered low-cost signaling (“we’re doing something”) with marginal aerosol benefits in controlled settings but poor real-world adherence/impact against airborne spread. Lockdowns preserved “virgin” populations for vaccine rollout by delaying exposure—aligning with pharma timelines & suppressing early treatment data.
Behaviorally: humans in crisis crave authority & rituals. Elites (often remote-working, low personal risk) imposed costs on working classes, small businesses & children—eroding social capital while accelerating wealth transfer to big tech/pharma. Natural immunity was downplayed because it competed with the product. This reflects a managerialist mindset: model-driven projections over historical precedent (e.g., focused protection), plus political utility in disrupting normalcy.
4. Why suppress alternatives like ivermectin & HCQ?
Early repurposed drugs threatened the EUA pathway (requiring no adequate alternatives) & billion-dollar novel vaccine monopolies. Regulatory capture media amplification turned debate into “misinfo.” Trials were designed/cherry-picked for failure (wrong dosing/timing), while observational data from frontline doctors was dismissed.
Psychologically & economically: pharma margins favor patented assets. Admitting cheap generics worked undermines the “novel threat demands novel solution” frame. This cements centralized authority—CDC/Fauci as arbiters—over decentralized medicine. It reveals how “following the science” often follows the money & narrative control.
Continued…